# Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)

> **NCT06781255** · PHASE1 · TERMINATED · sponsor: **Michelle Abou-Jaoude** · enrollment: 1 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Kamuvudine-9

## Key facts

- **NCT ID:** NCT06781255
- **Lead sponsor:** Michelle Abou-Jaoude
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-03-13
- **Primary completion:** 2026-02-25
- **Final completion:** 2026-02-25
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low recruitment outcome
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06781255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06781255, "Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06781255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*